Flurablastin

Flurablastin may be available in the countries listed below.

Ingredient matches for Flurablastin

Fluorouracil

Fluorouracil is reported as an ingredient of Flurablastin in the following countries:

• Denmark


• Finland


• Iceland


• Norway

International Drug Name Search

Ovidrel injectable

Generic Name: human chorionic gonadotropin (HCG) (injectable) (HUE man KORE ee ON ik goe NAD oh TRO pin)

Brand Names: Novarel, Ovidrel, Pregnyl

What is HCG?

Human chorionic gonadotropin (HCG) is a hormone that supports the normal development of an egg in a woman's ovary, and stimulates the release of the egg during ovulation.

HCG is used to cause ovulation and to treat infertility in women, and to increase sperm count in men. HCG is also used in young boys when their testicles have not dropped down into the scrotum normally. This can be caused by a pituitary gland disorder.

HCG may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about HCG?

Human chorionic gonadotropin (HCG) is given as an injection under the skin or into a muscle. If you use this medicine at home, your doctor, nurse, or pharmacist will give you specific instructions on how and where to inject this medicine. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles and syringes.

Call your doctor at once if you have any of these signs of a blood clot: pain, warmth, redness, numbness, or tingling in your arm or leg; confusion, extreme dizziness, or severe headache.

Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS), especially after the first treatment cycle. OHSS can be a life-threatening condition. Call your doctor right away if you have any symptoms of OHSS: severe pelvic pain, swelling of the hands or legs, stomach pain and swelling, shortness of breath, weight gain, diarrhea, nausea or vomiting, and urinating less than normal.

HCG can cause early puberty in young boys. Call your doctor if a boy using this medicine shows early signs of puberty, such as a deepened voice, pubic hair growth, and increased acne or sweating.

Using this medicine can increase your chances of having a multiple pregnancy (twins, triplets, quadruplets, etc). A multiple pregnancy is a high-risk pregnancy for the mother and for the babies. Follow your doctor's instructions about any special care you may need during your pregnancy.

Although HCG can help you become pregnant, this medication is in the FDA pregnancy category X. This means that using the medication once you are pregnant can cause birth defects in the baby. Do not use this medication if you are pregnant. Tell your doctor right away if you become pregnant during treatment.

What should I discuss with my healthcare provider before using HCG?

You should not use this medication if you have ever had an allergic reaction to HCG, or if you have:

• 
  

  early puberty (also called precocious puberty); or

  
  


• 
  

  a hormone-related cancer (such as prostate cancer).

  
  

If you have any of these other conditions, you may need a dose adjustment or special tests to safely use this medication:

• 
  

  a thyroid or adrenal gland disorder;

  
  


• 
  

  an ovarian cyst;

  
  


• 
  

  premature puberty;

  
  


• 
  

  cancer or a tumor of the breast, ovary, uterus, prostate, hypothalamus, or pituitary gland;

  
  


• 
  

  undiagnosed uterine bleeding;

  
  


• 
  

  heart disease;

  
  


• kidney disease;


• 
  

  epilepsy;

  
  


• 
  

  migraines; or

  
  


• 
  

  asthma.

  
  

Although HCG can help you become pregnant, this medication is in the FDA pregnancy category X. This means that using the medication once you are pregnant can cause birth defects in the baby. Do not use this medication if you are pregnant. Tell your doctor right away if you become pregnant during treatment. It is not known whether HCG passes into breast milk. Do not use HCG without telling your doctor if you are breast-feeding a baby.

How should I use HCG?

Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.

HCG is given as an injection under the skin or into a muscle. Your doctor, nurse, or other healthcare provider will give you this injection. You may be shown how to inject your medicine at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles and syringes.

Use each disposable needle only one time. Throw away used needles in a puncture-proof container (ask your pharmacist where you can get one and how to dispose of it). Keep this container out of the reach of children and pets.

To be sure this medication is helping your condition, your doctor will need to check you on a regular basis. Do not miss any scheduled appointments.

Some brands of HCG come in powder form with a separate liquid that you must mix together and draw into a syringe. Other brands are provided in single-dose prefilled syringes.

Do not use the medication if it has changed colors or the liquid has any particles in it. Call your doctor for a new prescription. Store the powder form of HCG at room temperature away from light, moisture, and heat. After mixing the powder with the liquid you must keep the mixture in the refrigerator. If you are using the Pregnyl brand of HCG, throw away any mixed medicine that you have not used within 60 days after mixing. If you are using the Novarel brand of HCG, throw away any mixed medicine that you have not used within 30 days after mixing. Store Ovidrel prefilled syringes in the refrigerator. You may also store Ovidrel at room temperature protected from light, but you must use it within 30 days. Carefully follow the mixing, storage, and expiration instructions that come with the brand of HCG you are using. Ask your doctor or pharmacist if you have questions about how long your mixed medicine can be stored and at what temperature.

What happens if I miss a dose?

Contact your doctor if you miss a dose of HCG.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of HCG is not expected to produce life-threatening symptoms.

What should I avoid while using HCG?

Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using HCG.

HCG side effects

Stop using HCG and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these signs of a blood clot: pain, warmth, redness, numbness, or tingling in your arm or leg; confusion, extreme dizziness, or severe headache.

Some women using this medicine have developed a condition called ovarian hyperstimulation syndrome (OHSS), especially after the first treatment cycle. OHSS can be a life-threatening condition. Call your doctor right away if you have any of the following symptoms of OHSS:

• 
  

  severe pelvic pain;

  
  


• 
  

  swelling of the hands or legs;

  
  


• 
  

  stomach pain and swelling;

  
  


• 
  

  shortness of breath;

  
  


• 
  

  weight gain;

  
  


• 
  

  diarrhea;

  
  


• 
  

  nausea or vomiting; or

  
  


• 
  

  urinating less than normal.

  
  

This medication can cause early puberty in young boys. Call your doctor if a boy using this medicine shows early signs of puberty, such as a deepened voice, pubic hair growth, and increased acne or sweating.

Less serious side effects may include:

• 
  

  headache;

  
  


• 
  

  feeling restless or irritable;

  
  


• 
  

  mild swelling or water weight gain;

  
  


• 
  

  depression;

  
  


• 
  

  breast tenderness or swelling; or

  
  


• 
  

  pain, swelling, or irritation where the injection is given.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect HCG?

There may be other drugs that can interact with HCG. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

More Ovidrel resources

• Ovidrel Side Effects (in more detail)
• Ovidrel Use in Pregnancy & Breastfeeding
• Ovidrel Drug Interactions
• Ovidrel Support Group
• 1 Review for Ovidrel - Add your own review/rating

Compare Ovidrel with other medications

• Female Infertility
• Hypogonadism, Male
• Ovulation Induction
• Prepubertal Cryptorchidism

Where can I get more information?

• Your doctor or pharmacist can provide more information about HCG.

See also: Ovidrel side effects (in more detail)

Toldimfos Sodium

Toldimfos Sodium may be available in the countries listed below.

Ingredient matches for Toldimfos Sodium

Toldimfos

Toldimfos Sodium (BANM) is also known as Toldimfos (Rec.INN)

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Strontium Chloride SR-89

Ingredient matches for Strontium Chloride SR-89

Strontium-89 Chloride

Strontium Chloride SR-89 (USAN) is known as Strontium-89 Chloride in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Verapamilo MK

Verapamilo MK may be available in the countries listed below.

Ingredient matches for Verapamilo MK

Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapamilo MK in the following countries:

• Belize


• Colombia


• Costa Rica


• Dominican Republic


• El Salvador


• Guatemala


• Honduras


• Nicaragua


• Panama

International Drug Name Search

Neocard

Neocard may be available in the countries listed below.

Ingredient matches for Neocard

Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Neocard in the following countries:

• Bangladesh

International Drug Name Search

Sorest

Sorest may be available in the countries listed below.

Ingredient matches for Sorest

Fluvoxamine

Fluvoxamine maleate (a derivative of Fluvoxamine) is reported as an ingredient of Sorest in the following countries:

• India

International Drug Name Search

Glide

Glide may be available in the countries listed below.

Ingredient matches for Glide

Glipizide

Glipizide is reported as an ingredient of Glide in the following countries:

• India

International Drug Name Search

Ciplocom

Ciplocom may be available in the countries listed below.

Ingredient matches for Ciplocom

Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Ciplocom in the following countries:

• Peru

International Drug Name Search

Lo Loestrin Fe

Lo Loestrin Fe is a brand name of ethinyl estradiol/norethindrone, approved by the FDA in the following formulation(s):

LO LOESTRIN FE (ethinyl estradiol; norethindrone acetate - tablet; oral)

• 
  Manufacturer: WARNER CHILCOTT CO
  
  Approval date: October 21, 2010
  
  Strength(s): 0.01MG,0.01MG;1MG,N/A ^[RLD]

Has a generic version of Lo Loestrin Fe been approved?

No. There is currently no therapeutically equivalent version of Lo Loestrin Fe available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lo Loestrin Fe. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
  Patent 5,552,394
  Issued: September 3, 1996
  Inventor(s): Hodgen; Gary D.
  Assignee(s): The Medical College of Hampton Roads
  A method of female contraception which is characterized by a reduced incidence of breakthrough bleeding after the first cycle involves monophasicly administering a combination of estrogen and progestin for 23-25 consecutive days of a 28 day cycle in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively and in which the weight ratio of estrogen to progestin is at least 1:45 calculated as ethinyl estradiol to norethindrone acetate.
  
  Patent expiration dates:
  
  
  • July 22, 2014
    
    ✓ 
    Patent use: LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION
  
  



• 
  Extended estrogen dosing contraceptive regimen
  Patent 7,704,984
  Issued: April 27, 2010
  Inventor(s): Boissonneault; Roger M.
  Assignee(s): Warner Chilcott Company, LLC
  A method of contraception that provides for sequentially administering to a female of child bearing age: (a) a first composition containing a progestin in an amount equivalent to about 0.3 to about 1.5 mg norethindrone acetate and an estrogen in an amount equivalent to about 5 to about 20 mcg of ethinyl estradiol for about 22 to about 26 days; (b) a second composition containing an estrogen in an amount equivalent to about 5 to about 20 mcg of ethinyl estradiol for about 2 to about 3 days and an optional third composition that is a placebo provided that (i) if estrogen administration is continuous then the first composition is administered for 25 to 26 days, the second composition is administered for 2 to 3 days and no third composition is administered and (ii) if estrogen administration is not continuous then the first composition is administered for 22 to 24 days, the second composition is administered for 2 to 3 days and the third composition is administered for 1 to 4 days. The total cycle length is 28 days, with the first composition administered on day 1 of the menstrual cycle, defined as the first day of menstrual bleeding, or on the first Sunday after the first day of the menstrual cycle.
  
  Patent expiration dates:
  
  
  • February 2, 2029
    
    ✓ 
    Patent use: LO LOESTRIN FE IS INDICATED FOR THE PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOF OF CONTRACEPTION
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 21, 2013 - NEW PRODUCT
  
  

See also...

• Lo Loestrin Fe Consumer Information (Drugs.com)
• Lo Loestrin Fe Consumer Information (Wolters Kluwer)
• Lo Loestrin Fe Consumer Information (Cerner Multum)
• Lo Loestrin Fe Advanced Consumer Information (Micromedex)
• Ortho-Novum Consumer Information (Drugs.com)
• Norethindrone/Ethinyl Estradiol Consumer Information (Wolters Kluwer)
• Norethindrone/Ethinyl Estradiol (HRT) Consumer Information (Wolters Kluwer)
• Norethindrone/Ethinyl Estradiol Chewable Tablets Consumer Information (Wolters Kluwer)
• Norethindrone/Ethinyl Estradiol Tablets Consumer Information (Wolters Kluwer)
• Ethinyl estradiol and norethindrone Consumer Information (Cerner Multum)
• Ethinyl estradiol and norethindrone HRT Consumer Information (Cerner Multum)
• Norethindrone, ethinyl estradiol, and ferrous fumarate Advanced Consumer Information (Micromedex)

Enterobene

Enterobene may be available in the countries listed below.

Ingredient matches for Enterobene

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Enterobene in the following countries:

• Austria

International Drug Name Search

Epozil

Epozil may be available in the countries listed below.

Ingredient matches for Epozil

Cefprozil

Cefprozil is reported as an ingredient of Epozil in the following countries:

• Bangladesh

International Drug Name Search

Neostigminemethylsulfaat CF

Neostigminemethylsulfaat CF may be available in the countries listed below.

Ingredient matches for Neostigminemethylsulfaat CF

Neostigmine

Neostigmine metilsulfate (a derivative of Neostigmine) is reported as an ingredient of Neostigminemethylsulfaat CF in the following countries:

• Netherlands

International Drug Name Search

Cortes

Cortes may be available in the countries listed below.

Ingredient matches for Cortes

Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Cortes in the following countries:

• Japan

International Drug Name Search